
Breaking News: M.T. 3’s Lavurchin Now Approved as a Radiosensitizer for Dogs in Japan!
Welcome to the Wonderful World of LAVURCHIN®: A Breakthrough in Canine Cancer Treatment Introduction Today, Malignant Tumor Treatment Technologies, Inc. (M.T.3) has made a groundbreaking announcement that is sure to bring hope and relief to countless dog owners around the world. The Ministry of Agriculture, Forestry, and Fisheries in Japan has officially approved LAVURCHIN® as…